annual ROE:
-254.98%-195.65%(-329.77%)Summary
- As of today (September 10, 2025), ARWR annual return on equity is -254.98%, with the most recent change of -195.65% (-329.77%) on September 30, 2024.
- During the last 3 years, ARWR annual ROE has fallen by -222.62% (-687.95%).
- ARWR annual ROE is now -736.34% below its all-time high of 40.07%, reached on September 30, 2019.
Performance
ARWR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-44.51%-0.71%(-1.62%)Summary
- As of today (September 10, 2025), ARWR quarterly return on equity is -44.51%, with the most recent change of -0.71% (-1.62%) on June 30, 2025.
- Over the past year, ARWR quarterly ROE has increased by +118.66% (+72.72%).
- ARWR quarterly ROE is now -222.72% below its all-time high of 36.27%, reached on September 30, 2019.
Performance
ARWR quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ARWR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -329.8% | +72.7% |
| 3 y3 years | -688.0% | -24.0% |
| 5 y5 years | -736.3% | -613.3% |
ARWR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -688.0% | at low | -29.1% | +82.8% |
| 5 y | 5-year | -736.3% | at low | -613.3% | +82.8% |
| alltime | all time | -736.3% | at low | -222.7% | +96.8% |
ARWR ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -44.51%(+1.6%) |
| Mar 2025 | - | -43.80%(-83.1%) |
| Dec 2024 | - | -258.73%(+26.1%) |
| Sep 2024 | -254.98%(+329.8%) | -205.10%(+25.7%) |
| Jun 2024 | - | -163.17%(+23.2%) |
| Mar 2024 | - | -132.39%(+49.0%) |
| Dec 2023 | - | -88.84%(+65.5%) |
| Sep 2023 | -59.33%(+39.0%) | -53.69%(+24.5%) |
| Jun 2023 | - | -43.12%(+25.1%) |
| Mar 2023 | - | -34.48%(-6.2%) |
| Dec 2022 | - | -36.77%(-11.4%) |
| Sep 2022 | -42.67%(+31.9%) | -41.51%(+15.7%) |
| Jun 2022 | - | -35.89%(+35.8%) |
| Mar 2022 | - | -26.42%(-38.8%) |
| Dec 2021 | - | -43.19%(+35.4%) |
| Sep 2021 | -32.36%(+35.1%) | -31.90%(+16.1%) |
| Jun 2021 | - | -27.48%(+17.7%) |
| Mar 2021 | - | -23.34%(+9.3%) |
| Dec 2020 | - | -21.36%(+10.7%) |
| Sep 2020 | -23.96%(-159.8%) | -19.29%(+209.1%) |
| Jun 2020 | - | -6.24%(-318.2%) |
| Mar 2020 | - | 2.86%(-85.6%) |
| Dec 2019 | - | 19.85%(-45.3%) |
| Sep 2019 | 40.07%(-164.8%) | 36.27%(+26.7%) |
| Jun 2019 | - | 28.63%(+308.4%) |
| Mar 2019 | - | 7.01%(-126.5%) |
| Dec 2018 | - | -26.44%(-55.2%) |
| Sep 2018 | -61.84%(+58.2%) | -58.96%(-1.2%) |
| Jun 2018 | - | -59.66%(+20.5%) |
| Mar 2018 | - | -49.52%(+20.3%) |
| Dec 2017 | - | -41.16%(+9.2%) |
| Sep 2017 | -39.09%(-51.1%) | -37.70%(-28.6%) |
| Jun 2017 | - | -52.78%(-26.0%) |
| Mar 2017 | - | -71.34%(-20.0%) |
| Dec 2016 | - | -89.18%(-6.1%) |
| Sep 2016 | -79.87%(+19.7%) | -94.95%(+5.1%) |
| Jun 2016 | - | -90.37%(+23.3%) |
| Mar 2016 | - | -73.30%(+3.0%) |
| Dec 2015 | - | -71.17%(+7.8%) |
| Sep 2015 | -66.72%(+8.9%) | -66.02%(+13.8%) |
| Jun 2015 | - | -58.01%(+13.0%) |
| Mar 2015 | - | -51.32%(+11.6%) |
| Dec 2014 | - | -45.98%(+1.5%) |
| Sep 2014 | -61.26%(-65.6%) | -45.31%(-6.8%) |
| Jun 2014 | - | -48.61%(-27.4%) |
| Mar 2014 | - | -66.99%(-45.6%) |
| Dec 2013 | - | -123.05%(-36.6%) |
| Sep 2013 | -178.31%(-6.1%) | -193.95%(+8.0%) |
| Jun 2013 | - | -179.53%(-34.9%) |
| Mar 2013 | - | -275.62%(+41.8%) |
| Dec 2012 | - | -194.40%(+17.1%) |
| Sep 2012 | -189.88% | -165.96%(+14.9%) |
| Jun 2012 | - | -144.42%(+53.9%) |
| Mar 2012 | - | -93.83%(+43.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | -65.31%(-6.5%) |
| Sep 2011 | -81.56%(-28.6%) | -69.87%(+0.8%) |
| Jun 2011 | - | -69.30%(+10.5%) |
| Mar 2011 | - | -62.71%(-25.7%) |
| Dec 2010 | - | -84.44%(-11.1%) |
| Sep 2010 | -114.17%(-49.3%) | -94.94%(-24.3%) |
| Jun 2010 | - | -125.40%(-38.0%) |
| Mar 2010 | - | -202.37%(-23.5%) |
| Dec 2009 | - | -264.45%(-15.7%) |
| Sep 2009 | -225.03%(+26.8%) | -313.64%(+7.5%) |
| Jun 2009 | - | -291.79%(+9.9%) |
| Mar 2009 | - | -265.51%(+36.0%) |
| Dec 2008 | - | -195.29%(+28.4%) |
| Sep 2008 | -177.41%(+40.4%) | -152.04%(+11.4%) |
| Jun 2008 | - | -136.47%(-1.9%) |
| Mar 2008 | - | -139.16%(+4.8%) |
| Dec 2007 | - | -132.75%(+9.3%) |
| Sep 2007 | -126.36%(+85.4%) | -121.49%(+6.9%) |
| Jun 2007 | - | -113.62%(+41.1%) |
| Mar 2007 | - | -80.54%(+24.3%) |
| Dec 2006 | - | -64.81%(-2.1%) |
| Sep 2006 | -68.14%(+95.6%) | -66.22%(+108.8%) |
| Jun 2006 | - | -31.72%(-11.9%) |
| Mar 2006 | - | -36.01%(+17.8%) |
| Dec 2005 | - | -30.58%(+28.5%) |
| Sep 2005 | -34.84%(-19.9%) | -23.80%(-38.7%) |
| Jun 2005 | - | -38.80%(+39.0%) |
| Mar 2005 | - | -27.91%(-41.5%) |
| Dec 2004 | - | -47.70%(+31.9%) |
| Sep 2004 | -43.47%(+547.8%) | -36.17%(+88.9%) |
| Jun 2004 | - | -19.15%(+35.1%) |
| Mar 2004 | - | -14.17%(-99.0%) |
| Dec 2003 | - | -1412.97%(<-9900.0%) |
| Sep 2003 | -6.71%(-142.3%) | 10.50%(-10.9%) |
| Jun 2003 | - | 11.79%(-18.1%) |
| Mar 2003 | - | 14.40%(+57.9%) |
| Dec 2002 | - | 9.12%(-14.4%) |
| Sep 2002 | 15.88%(+11.5%) | 10.66%(-4.1%) |
| Jun 2002 | - | 11.11%(+46.6%) |
| Mar 2002 | - | 7.58%(-30.1%) |
| Dec 2001 | - | 10.85%(+13.4%) |
| Sep 2001 | 14.24%(+16.8%) | 9.57%(+38.7%) |
| Jun 2001 | - | 6.90%(-23.0%) |
| Mar 2001 | - | 8.96%(-4.3%) |
| Dec 2000 | - | 9.36%(-16.2%) |
| Sep 2000 | 12.19%(-67.0%) | 11.17%(-11.2%) |
| Jun 2000 | - | 12.58%(-56.5%) |
| Mar 2000 | - | 28.94%(+49.6%) |
| Dec 1999 | - | 19.35%(+38.9%) |
| Sep 1999 | 36.99%(+1787.2%) | 13.93%(-3.3%) |
| Jun 1999 | - | 14.40%(+2260.7%) |
| Mar 1999 | - | 0.61% |
| Sep 1998 | 1.96%(-94.1%) | - |
| Sep 1997 | 33.17% | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual return on equity?
- What is the all time high annual ROE for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of ARWR is -254.98%
What is the all time high annual ROE for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual return on equity is 40.07%
What is Arrowhead Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, ARWR annual return on equity has changed by -195.65% (-329.77%)
What is Arrowhead Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of ARWR is -44.51%
What is the all time high quarterly ROE for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly return on equity is 36.27%
What is Arrowhead Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, ARWR quarterly return on equity has changed by +118.66% (+72.72%)